Inhibits lysosomal acidification and prevents macrophage antigen presentation Inhibits formation of the NLRP3 inflammasome and thus release of IL-1β Reduces inflammation in models of multiple sclerosis, type 1 diabetes, and allergic asthma. This evidence concerns the gene NLRP3 and type 1 diabetes mellitus.